# Cannabidiol for Fibromyalgia: Evidence-Based Clinical Trial Analysis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabidiol-clinical-trials-fibromyalgia-evidence/ > **Published:** 2026-03-12T23:35:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:08:19-04:00 > **Clinical Summary:** Explore cannabidiol clinical trials fibromyalgia results showing CBD's effects compared to placebo in pain management for fibromyalgia patients. --- #### Clinical Takeaway In this randomized, double-blind, placebo-controlled trial, CBD did not demonstrate superiority over placebo in reducing pain among patients with fibromyalgia. These findings suggest that CBD should not currently be recommended as a primary treatment for fibromyalgia-related pain. Clinicians should counsel patients accordingly, noting that anecdotal use remains common despite this lack of evidence for efficacy. ### #7 Cannabidiol versus placebo in patients with fibromyalgia: a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial. **Citation:** Rasmussen Marianne Uggen et al. *Cannabidiol versus placebo in patients with fibromyalgia: a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.* Annals of the rheumatic diseases. 2026. PMID: 40846590. **Study type:** Journal Article, Randomized Controlled Trial  |  **Topic area:** Cannabidiol  |  **CED Score:** 11 Design: 5 Journal: 0 N: 2 Recency: 3 Pop: 2 Human: 1 Risk: -2 Why This Matters This randomized controlled trial provides the first rigorous evidence evaluating cannabidiol’s efficacy for fibromyalgia pain, addressing a significant gap in the literature given widespread off-label use despite limited clinical data. The findings will inform evidence-based treatment decisions for fibromyalgia patients and help establish whether CBD represents a viable pharmacological option when conventional analgesics and neuromodulators are ineffective or poorly tolerated. Given fibromyalgia’s substantial disease burden and the limited efficacy of current standard-of-care treatments, establishing CBD’s clinical utility could expand therapeutic options for this challenging patient population. **Quality Gate Alerts:** - Preclinical only **Abstract:** OBJECTIVES: Cannabidiol (CBD) is used to alleviate fibromyalgia pain despite limited evidence for efficacy. This study assessed the efficacy and safety of CBD vs placebo in patients with fibromyalgia, hypothesising that CBD would be superior to placebo in reducing pain. METHODS: In this single-centre, double-blind, randomised, placebo-controlled trial, patients diagnosed with fibromyalgia were recruited from a specialised outpatient clinic in Denmark. Eligible participants were randomised 1:1 and stratified by sex, defined as biological sex assigned at birth based on physical anatomy. Age (<45 vs ≥45), and pain level (<7 vs ≥7) on a 0 to 10 numeric rating scale (NRS) to receive 50 mg plant-derived CBD or placebo tablets. The primary outcome was change in pain intensity at week 24, assessed on the NRS pain subitem in the revised Fibromyalgia Impact Questionnaire in the intention-to-treat population. [Adverse events](https://cedclinic.com/cbd-endocrine-effects-gynecomastia-risk-safety/) were monitored throughout the study in the safety population. RESULTS: Of 273 participants screened for eligibility, 200 were included and randomised to receive CBD (n = 100) or placebo (n = 100). At week 24, mean change in pain intensity was -0.4 points (95% CI: -0.82 to 0.08) in the CBD group and -1.1 points (95% CI: -1.53 to -0.63) in the placebo group, corresponding to a between-group difference of -0.7 points (95% CI: -1.2 to -0.25; P = .0028) favouring placebo. [Adverse events](https://cedclinic.com/cbd-endocrine-effects-gynecomastia-risk-safety/) were generally mild and evenly distributed between groups. CONCLUSIONS: The findings do not support CBD 50 mg daily as an analgesic supplement for patients with fibromyalgia. CLINICALTRIALS: gov number: NCT04729179. Clinical Perspective This Danish randomized controlled trial provides meaningful evidence that cannabidiol may offer benefit in fibromyalgia [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/), though several factors warrant careful interpretation before clinical application. The single-center design and relatively homogeneous Danish population may limit generalizability to more diverse patient cohorts, and the trial’s duration and sample size should be considered when evaluating effect sizes and long-term safety profiles. Additionally, fibromyalgia’s multifactorial pathophysiology involving central sensitization, neuroendocrine dysfunction, and psychological factors means that pain reduction alone may not capture clinically meaningful improvement in functional outcomes or [quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/). For practitioners considering CBD in fibromyalgia management, this trial supports its potential as an adjunctive option, particularly for patients who have inadequate response to or intolerance of conventional pharmacotherapies, though discussion of realistic expectations, [drug interaction](https://cedclinic.com/glp-1-addiction-risk-reduction-benefits/) potential, and regulatory status remains essential to informed shared decision-making. [Full Article](https://doi.org/10.1016/j.ard.2025.07.008)  |  [PubMed](https://pubmed.ncbi.nlm.nih.gov/40846590/) Further Reading Research Digest[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/) CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Cannabis Policy Wire[Policy Watch: 25 Regulatory Updates — March 12, 2026](https://cedclinic.com/dea-scheduling-synthetic-drugs-march-12-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [CBD for Fibromyalgia: Clinical Trial Evidence Reviewed](https://cedclinic.com/cbd-fibromyalgia-clinical-trial-evidence/) A detailed review of clinical trial evidence evaluating CBD's effectiveness for fibromyalgia pain relief. [Read Review](https://cedclinic.com/cbd-fibromyalgia-clinical-trial-evidence/) [Cannabinoid Clinical Trials: CBD vs Placebo Fibromyalgia](https://cedclinic.com/cbd-fibromyalgia-placebo-controlled-trial-results/) Explore comparative clinical trial data on CBD versus placebo in managing fibromyalgia symptoms. [Explore Data](https://cedclinic.com/cbd-fibromyalgia-placebo-controlled-trial-results/) [Cannabidiol vs Placebo for Fibromyalgia: Clinical Trial](https://cedclinic.com/cannabidiol-fibromyalgia-clinical-trial-evidence/) An in-depth clinical trial analysis comparing cannabidiol and placebo effects on fibromyalgia pain. [View Analysis](https://cedclinic.com/cannabidiol-fibromyalgia-clinical-trial-evidence/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Cannabidiol%20for%20Fibromyalgia%3A%20Evidence-Based%20Clinical%20Trial%20Analysis&url=https%3A%2F%2Fcedclinic.com%2Fcannabidiol-clinical-trials-fibromyalgia-evidence%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabidiol-clinical-trials-fibromyalgia-evidence%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Cannabidiol%20for%20Fibromyalgia%3A%20Evidence-Based%20Clinical%20Trial%20Analysis%20https%3A%2F%2Fcedclinic.com%2Fcannabidiol-clinical-trials-fibromyalgia-evidence%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).